Spanish operator of a network of eye clinics across Europe.
AI-generated insights about Clinica Baviera S.A. from various financial sources
A stable 'compounder' stock with consistent 17% annual sales growth and high 18% free cash flow margins, benefiting from long-term demographic trends. Current valuation is considered 'more than reasonable'.
A stable 'compounder' stock with consistent 17% annual sales growth and high 18% free cash flow margins, benefiting from long-term demographic trends. Current valuation is considered 'more than reasonable'.